SMAD4 and Hepatic fibrosis: Some studies have also revealed that miR-122 can improve liver fibrosis by reducing the expression of decapentaplegic protein 4 (Smad4), a primary protein in the TGF-β1 signaling pathway, and limiting collagen production in HSCs [127,128].